ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,933Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 133

$597K Total Retail Price of All Prescriptions

Rank: 4 out of 133

901 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 11,986 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
CARVEDILOL 1,200 1,083 1 1
SIMVASTATIN 951 902 2 3
LISINOPRIL 761 710 3 2
AMLODIPINE BESYLATE 696 653 4 4
METOPROLOL SUCCINATE 562 544 5 7
FUROSEMIDE 543 508 6 6
DIGOXIN 488 441 7 13
WARFARIN SODIUM 476 456 8 8
NIASPAN 431 391 9 27
POTASSIUM CHLORIDE 431 414 9 14
METOPROLOL TARTRATE 350 331 11 5
LOSARTAN POTASSIUM 343 340 12 15
ISOSORBIDE MONONITRATE ER 319 290 13 11
CRESTOR 260 252 14 19
CLOPIDOGREL 237 183 15 9
DILTIAZEM 24HR CD 218 203 16 24
SOTALOL 207 201 17 17
AMIODARONE HCL 201 190 18 23
PLAVIX 173 152 19 12
DILTIAZEM 24HR ER 154 150 20 36
EFFIENT 154 133 20 38
PANTOPRAZOLE SODIUM 151 150 22 33
OMEPRAZOLE 150 135 23 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 127 24 45
MULTAQ 129 128 25 52
BENAZEPRIL HCL 125 124 26 53
NITROSTAT 107 87 27 22
CARTIA XT 101 87 28 63
DILTIAZEM ER 101 95 28 40
NITROGLYCERIN PATCH 101 88 28 32
KLOR-CON M20 99 70 31 28
KLOR-CON M10 96 94 32 69
SPIRONOLACTONE 95 87 33 21
ATORVASTATIN CALCIUM 94 82 34 10
LEVOTHYROXINE SODIUM 94 93 34 43
LOSARTAN-HYDROCHLOROTHIAZIDE 82 74 36 37
FLECAINIDE ACETATE 75 75 37 26
BUMETANIDE 75 66 37 31
BENAZEPRIL-HYDROCHLOROTHIAZIDE 75 70 37 86
PRADAXA 72 72 40 25
PACERONE 71 71 41 79
BYSTOLIC 69 69 42 30
TAMSULOSIN HCL 64 64 43 94
ZOLPIDEM TARTRATE 63 63 44 66
VYTORIN 60 60 45 57
ATENOLOL 56 54 46 16
CLONIDINE HCL 56 36 46 42
AMLODIPINE BESYLATE-BENAZEPRIL 54 51 48 81
FENOFIBRATE 52 50 49 62
VERAPAMIL ER 52 47 49 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.